ClinConnect ClinConnect Logo
Search / Trial NCT05648617

Effectiveness of Protein Supplementation on Frailty Improvement, Muscle Strength and Physical Performance Among Pre-Frail Elderly People

Launched by UNIVERSITI PUTRA MALAYSIA · Dec 8, 2022

Trial Information

Current as of July 06, 2025

Unknown status

Keywords

Frailty Protein Supplements Elderlies Muscle Strength Physical Performance

ClinConnect Summary

This clinical trial is looking at whether protein supplements can help improve frailty, muscle strength, and physical performance in older adults who are considered "pre-frail." This means they show some signs of weakness but are not completely frail yet. Participants in the study will be divided into two groups: one group will receive a protein supplement called SUSTINEX Hydrolyzed Whey Protein and will be asked to consume 30 grams of it daily by adding it to their meals or drinks. The other group will not receive the supplement and will continue with their usual care.

To be eligible for this trial, participants must be men or women aged 60 or older who meet specific criteria indicating they are pre-frail. They should be willing to follow the study rules and give consent to participate. However, individuals who are already frail, have certain chronic diseases, or have had recent surgeries or fractures won't be able to join. The trial aims to understand if the protein supplement can positively impact the health and daily activities of older adults, which could be an important step in helping them maintain their independence and quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pre-frail men or women aged 60 years and above (Fried criteria: score ≥1 but \<3 out of 5).
  • Willing to give informed consent to be randomized to either the protein supplement or control group
  • Willing to follow the study protocol.
  • Exclusion Criteria:
  • Non or Frail elderlies (Fried criteria)
  • Diagnosed with chronic diseases include: (heart-related disease, COPD, stroke, cancer, asthma, renal dysfunction, terminally ill), bedridden.
  • Already involved or still participating in any health interventional studies.
  • Participants who consume protein supplements
  • Any sustained fracture (hip, vertebrata) in past six month, any surgery (hip, abdominal area) in past six month

About Universiti Putra Malaysia

Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.

Locations

Patients applied

0 patients applied

Trial Officials

Associate Professor Dr Siti Nur 'Asyura B Adznam, Ass.prof

Principal Investigator

University Putra Malaysia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials